Lysyl oxidase inhibitors in colorectal cancer progression
The lysine oxidase (LOX) family, consisting of LOX and LOX-like-1–4 (LOXL1–LOXL4), catalyses the cross-linking reaction of collagen and elastin in the extracellular matrix (ECM). Numerous studies have demonstrated that LOX family members are dysregulated in a variety of cancers, including colorectal...
Saved in:
Main Authors: | Muxian Liu, Jie Wang, Meihong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324003590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising LOX proteins for cartilage-targeting osteoarthritis therapy
by: Luca Morici, et al.
Published: (2025-02-01) -
Biotechnological Phytocomplex of <i>Zanthoxylum piperitum</i> (L.) DC. Enhances Collagen Biosynthesis In Vitro and Improves Skin Elasticity In Vivo
by: Giovanna Rigillo, et al.
Published: (2025-01-01) -
Colorectal cancer spectrum: From subtypes and epidemiology to oncotherapies
by: Nidhi Agrawal, et al.
Published: (2025-04-01) -
Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species
by: Chenxia Han, et al.
Published: (2025-01-01) -
PRMT6 promotes colorectal cancer progress via activating MYC signaling
by: Xin Zhang, et al.
Published: (2025-01-01)